PHAR Pharming Group N.V. - ADS, each representing 10 ordinary shares
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 5, 2026 10-K/10-Q Apr 13, 2026
$9.74
· of 52w range
· above low
· to high
$9.6252w low
$21.0752w high
P/E
4417.5
EPS
$0.00
your badges
52W Range
$10–$21
Analyst Rating
STRONG BUY
Price Target
$34
P/E
4417.5
ROE
1.1%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
PHAR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$9.74
P/E
4417.5
EPS
$0.00
ROE
1.1%
52W Range
$10–$21
PHAR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$0.002018-12-31 → 2025-12-31
Free Cash Flow$54M2020-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | PHAR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | 4417.55Y avg ≈822.6 | ≈822.6 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | PHAR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | 0.63%5Y avg ≈0.55% | ≈0.55% | · | · | |
| ROE | 1.1%5Y avg ≈1.2% | ≈1.2% | · | · | |
| ROIC | 1.8%5Y avg ≈1.4% | ≈1.4% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | PHAR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 2.65Y avg ≈4.1 | ≈4.1 | 6.1 | Low liquidity | |
| Quick Ratio | 1.75Y avg ≈2.7 | ≈2.7 | 4.0 | Low liquidity | |
| Interest Coverage | 131.85Y avg ≈51.1 | ≈51.1 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | PHAR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Inventory Turnover | 0.85Y avg ≈0.7 | ≈0.7 | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
16.6%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | $0.00 | $0.02 | -90.0% | |
| March 31, 2026 | $-0.01 | $0.01 | — | |
| Dec. 31, 2025 | $0.01 | $0.01 | — | |
| Sept. 30, 2025 | $0.01 | $-0.00 | — | |
| June 30, 2025 | $0.01 | $-0.03 | 123.3% | |
| March 31, 2025 | $0.01 | $0.01 | — | |
| Dec. 31, 2024 | $0.01 | $0.01 | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | $46M | $35M | $25M | $18M | $21M | $24M | $24M | |
| Gross Profit | $331M | $262M | $220M | $188M | $178M | $189M | $165M | |
| R&D Expense | $100M | $83M | $69M | $53M | $70M | $39M | $32M | |
| SG&A Expense | $80M | $71M | $56M | $46M | $37M | $24M | $21M | |
| Operating Income | $26M | $-9M | $-5M | $18M | $14M | $76M | $68M | |
| Interest Expense | $196.0K | $56.0K | $134.0K | $105.0K | $94.0K | $74.0K | $0 | |
| Pretax Income | $13M | $-8M | $-12M | $15M | $23M | $44M | $52M | |
| Income Tax | $10M | $3M | $-1M | $1M | $7M | $6M | $12M | |
| Net Income | $3M | $-12M | $-11M | $14M | $16M | $38M | $41M | |
| EPS (Basic) | $0.00 | $-0.02 | $-0.02 | $0.02 | $0.03 | $0.06 | $0.07 | |
| EPS (Diluted) | $0.00 | $-0.02 | $-0.02 | $0.02 | $0.02 | $0.06 | $0.06 | |
| Shares (Basic) | 688,773,370 | 671,347,279 | 657,020,521 | 648,676,119 | 642,007,692 | 636,268,929 | 626,315,013 | |
| Shares (Diluted) | 746,866,045 | 785,412,134 | 725,463,948 | 707,141,263 | 701,151,525 | 682,737,280 | 673,519,995 | |
| EBITDA | $26M | $-9M | $-5M | $18M | $20M | $72M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $145M | $55M | $62M | $207M | $192M | $205M | $74M | |
| Receivables | $55M | $55M | $46M | $28M | $30M | $36M | $29M | |
| Inventory | $65M | $56M | $57M | $42M | $27M | $21M | $16M | |
| Current Assets | $299M | $278M | $316M | $278M | $249M | $263M | $119M | |
| PP&E (Net) | $7M | $8M | $10M | $10M | $13M | $12M | $10M | |
| Intangibles | $136M | $61M | $71M | $75M | $84M | $94M | $79M | |
| Total Assets | $500M | $400M | $463M | $426M | $397M | $418M | $256M | |
| Accounts Payable | $106M | $67M | $73M | $54M | $42M | $48M | $41M | |
| Current Liabilities | $116M | $74M | $78M | $60M | $47M | $77M | $114M | |
| Retained Earnings | $-273M | $-275M | $-265M | $-256M | $-273M | $-296M | $-341M | |
| Stockholders' Equity | $277M | $221M | $219M | $205M | $193M | $183M | $117M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $6M | $6M | $5M | |
| Other Non-cash | · | · | · | · | $15M | $36M | · | |
| Operating Cash Flow | $55M | $-2M | $-17M | $22M | $38M | $84M | $74M | |
| CapEx | $749.0K | $790.0K | $1M | $1M | $11M | $5M | $3M | |
| Investing Cash Flow | $26M | $32M | $-129M | $5M | $-21M | $-16M | $-28M | |
| Financing Cash Flow | $1M | $-34M | $-1M | $-5M | $-28M | $61M | $-63M | |
| Free Cash Flow | $54M | $-3M | $-19M | $21M | $27M | $70M | · | |
| Levered FCF | $54M | $-3M | $-19M | $21M | $27M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | 0.63% | -2.7% | -2.4% | 3.3% | 3.9% | 11.1% | · | |
| ROE | 1.1% | -5.4% | -5.0% | 6.9% | 8.5% | 24.8% | · | |
| ROIC | 1.8% | -5.4% | -2.2% | 8.1% | 4.9% | 38.2% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | 3.8 | 4.1 | 4.6 | 5.3 | 3.4 | · | |
| Quick Ratio | 1.7 | 1.5 | 1.4 | 3.9 | 4.7 | 0.6 | · | |
| Interest Coverage | 131.8 | -153.9 | -40.2 | 173.6 | 144.3 | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Inventory Turnover | 0.8 | 0.6 | 0.5 | 0.5 | 0.9 | 1.2 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash Flow / Share | $0.07 | $-0.00 | $-0.02 | $0.03 | $0.05 | $0.11 | · | |
| EPS (TTM) | $0.00 | $-0.02 | $-0.02 | $0.02 | $0.02 | $0.06 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $3M | $-12M | $-11M | $14M | $16M | $38M | · | |
| P/E | 4417.5 | -559.2 | -714.4 | 580.5 | 388.7 | 276.3 | · | |
| Earnings Yield | 0.02% | -0.18% | -0.14% | 0.17% | 0.26% | 0.36% | · |
No quarterly filings for PHAR
We don't have SEC filings for this ticker yet.
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $3M | $-12M | $-11M | $14M | $16M |
| Diluted EPS | $0.00 | $-0.02 | $-0.02 | $0.02 | $0.02 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 2.6 | 3.8 | 4.1 | 4.6 | 5.3 |
| Quick Ratio | 1.7 | 1.5 | 1.4 | 3.9 | 4.7 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $54M | $-3M | $-19M | $21M | $27M |
Institutional owners (13F) 16 filers · $1.3M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
16
Value held
$1.3M
New positions
6
Exited positions
4
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 6 (+1 vs prior Q) | 4 (+1 vs prior Q) | 3 (+2 vs prior Q) | 6 (0 vs prior Q) | -3K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Silverberg Bernstein Capital Management LLC | $577,088 | 41,547 | 43.89% | Shares |
| Crossmark Global Holdings, Inc. | $168,998 | 12,463 | 12.85% | Shares |
| CITADEL ADVISORS LLC | $162,340 | 11,972 | 12.35% | Shares |
| MORGAN STANLEY | $159,735 | 11,500 | 12.15% | Shares |
| SmartHarvest Portfolios, LLC | $144,664 | 10,415 | 11.00% | Shares |
| Knoll Capital Management, LLC | $56,823 | 4,091 | 4.32% | Shares |
| Silver Grove Financial Group, Inc. | $14,876 | 1,071 | 1.13% | Shares |
| Nalls Sherbakoff Group, LLC | $12,084 | 870 | 0.92% | Shares |
| Global Retirement Partners, LLC | $6,334 | 456 | 0.48% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $4,167 | 300 | 0.32% | Shares |
| Optiver Holding B.V. | $4,136 | 305 | 0.31% | Shares |
| NewEdge Advisors, LLC | $2,596 | 187 | 0.20% | Shares |
| UBS Group AG | $542 | 39 | 0.04% | Shares |
| OSAIC HOLDINGS, INC. | $222 | 16 | 0.02% | Shares |
| Larson Financial Group LLC | $97 | 7 | 0.01% | Shares |
| Caitong International Asset Management Co., Ltd | $14 | 1 | 0.00% | Shares |
PHAR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 14 analysts
BUY
Median target
$37.50
+285.2%
7 50.0%
Strong Buy
6 42.9%
Buy
1 7.1%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
4 analysts · 2026-10-04Mean target $34.35 +252.8%
← Below all targets
Current price $9.74
Low$23.40
Mean$34.35
High$39.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F/A filed Apr 13, 2026